Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BIAF NASDAQ:BIYA NASDAQ:DXST NASDAQ:ISPC On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBIAFbioAffinity Technologies$0.79-4.9%$1.47$0.69▼$13.50$3.94M-1.11656,855 shs1.06 million shsBIYABaiya International Group$0.51+24.2%$0.84$0.28▼$24.70$660K2.5625.86 million shs77.79 million shsDXSTDecent$2.28+1.3%$2.31$1.50▼$62.00$4.08M-0.02637,480 shs60,581 shsISPCiSpecimen$2.29-4.6%$3.39$2.26▼$127.20$3.65M1.6370,025 shs40,362 shs7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBIAFbioAffinity Technologies-4.94%-6.46%-50.69%-76.23%-92.26%BIYABaiya International Group+24.21%-4.70%-36.53%-61.14%-97.18%DXSTDecent+1.33%+11.22%-27.16%-24.00%-92.59%ISPCiSpecimen-4.58%-16.12%-22.37%-56.00%-94.50%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBIAFbioAffinity Technologies$0.79-4.9%$1.47$0.69▼$13.50$3.94M-1.11656,855 shs1.06 million shsBIYABaiya International Group$0.51+24.2%$0.84$0.28▼$24.70$660K2.5625.86 million shs77.79 million shsDXSTDecent$2.28+1.3%$2.31$1.50▼$62.00$4.08M-0.02637,480 shs60,581 shsISPCiSpecimen$2.29-4.6%$3.39$2.26▼$127.20$3.65M1.6370,025 shs40,362 shs7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBIAFbioAffinity Technologies-4.94%-6.46%-50.69%-76.23%-92.26%BIYABaiya International Group+24.21%-4.70%-36.53%-61.14%-97.18%DXSTDecent+1.33%+11.22%-27.16%-24.00%-92.59%ISPCiSpecimen-4.58%-16.12%-22.37%-56.00%-94.50%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBIAFbioAffinity Technologies 1.00SellN/AN/ABIYABaiya International Group 1.00SellN/AN/ADXSTDecent 1.00SellN/AN/AISPCiSpecimen 1.00SellN/AN/ACurrent Analyst Ratings BreakdownLatest BIYA, DXST, BIAF, and ISPC Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/24/2026BIYABaiya International Group Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)5/1/2026DXSTDecent Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D)4/22/2026BIAFbioAffinity Technologies Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)4/21/2026ISPCiSpecimen Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)(Data available from 7/9/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBIAFbioAffinity Technologies$6.16M0.61N/AN/A$1.62 per share0.49BIYABaiya International Group$16.48M0.05N/AN/A$19.07 per share0.03DXSTDecent$12.95M0.32N/AN/A$7.86 per share0.29ISPCiSpecimen$1.93M1.80N/AN/A$14.57 per share0.16Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBIAFbioAffinity Technologies-$14.91M-$11.77N/AN/AN/A-280.53%-285.75%-143.71%8/19/2026 (Estimated)BIYABaiya International Group-$9.53MN/AN/AN/AN/AN/AN/AN/AN/ADXSTDecent-$320KN/AN/AN/AN/AN/AN/AN/AN/AISPCiSpecimen-$10.49M-$72.26N/AN/AN/A-1,080.16%-584.65%-142.48%8/4/2026 (Estimated)Latest BIYA, DXST, BIAF, and ISPC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/15/2026Q1 2026ISPCiSpecimenN/A-$6.66N/A-$6.66N/A$0.16 million5/8/2026Q1 2026BIAFbioAffinity Technologies-$2.40-$0.81+$1.59-$0.81$1.48 million$1.35 million4/30/2026Q4 2025BIYABaiya International GroupN/A$2.2930N/A$2.2930N/A$4.61 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthBIAFbioAffinity TechnologiesN/AN/AN/AN/AN/ABIYABaiya International GroupN/AN/AN/AN/AN/ADXSTDecentN/AN/AN/AN/AN/AISPCiSpecimenN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBIAFbioAffinity Technologies0.151.361.34BIYABaiya International GroupN/A5.545.54DXSTDecentN/A1.711.71ISPCiSpecimenN/A0.620.62Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBIAFbioAffinity Technologies1.64%BIYABaiya International GroupN/ADXSTDecentN/AISPCiSpecimen13.62%Insider OwnershipCompanyInsider OwnershipBIAFbioAffinity Technologies2.68%BIYABaiya International GroupN/ADXSTDecentN/AISPCiSpecimen12.20%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBIAFbioAffinity Technologies104.74 million4.62 millionNot OptionableBIYABaiya International Group241.61 millionN/AN/ADXSTDecent161.82 millionN/AN/AISPCiSpecimen601.52 million1.26 millionNot OptionableBIYA, DXST, BIAF, and ISPC HeadlinesRecent News About These CompaniesiSpecimen (NASDAQ:ISPC) Shares Down 4.6% - Should You Sell?3 hours ago | americanbankingnews.comiSpecimen Receives Nasdaq Noncompliance Notice, Listing at RiskJune 1, 2026 | tipranks.comiSpecimen Regains Nasdaq Compliance and Raises New CapitalMay 14, 2026 | theglobeandmail.comE.F. Hutton & Co. Serves as Exclusive Placement Agent on iSpecimen Inc. $2.5 Million Private PlacementMay 12, 2026 | globenewswire.comiSpecimen announces pricing of approximately $2.5M private placementMay 11, 2026 | msn.comiSpecimen Inc. Announces Pricing of Approximately $2.5 Million Private PlacementMay 8, 2026 | globenewswire.comiSpecimen Completes 1-for-40 Reverse Stock SplitMay 1, 2026 | tipranks.comiSpecimen IncApril 28, 2026 | edition.cnn.comiSpecimen Announces 1-for-40 Reverse Stock SplitApril 24, 2026 | newsfilecorp.comNTop pre-market gainers today — ISPC, WGRX, RAYA among stocks that are soaring before the bellApril 10, 2026 | msn.comiSpecimen is trending overnight — here's why ISPC stock surged 56% in the after-hours sessionApril 10, 2026 | msn.comiSpecimen Is Trending Overnight — Here's Why ISPC Stock Surged 56% In The After-Hours SessionApril 9, 2026 | benzinga.comiSpecimen Achieves 85% Reduction in Human Biospecimen Shipping TimeApril 9, 2026 | newsfilecorp.comNiSpecimen Delays Annual Report Filing BrieflyMarch 31, 2026 | tipranks.comCritical Survey: iSpecimen (NASDAQ:ISPC) vs. Progyny (NASDAQ:PGNY)March 27, 2026 | defenseworld.netDiSpecimen Achieves Rapid Procurement Milestone for Influenza ResearchMarch 16, 2026 | newsfilecorp.comNNasdaq Microcap Soars After Unveiling AI Tool Designed to Accelerate Medical ResearchMarch 14, 2026 | theglobeandmail.comiSpecimen Faces Ongoing Shareholder Quorum Challenges for MeetingMarch 13, 2026 | tipranks.comISpecimen (ISPC) stock rockets 43% after hours — here's why it's trendingMarch 13, 2026 | msn.comiSpecimen Launches AI Agent Revolutionizing Biospecimen MatchingMarch 12, 2026 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeBIYA, DXST, BIAF, and ISPC Company DescriptionsbioAffinity Technologies NASDAQ:BIAF$0.79 -0.04 (-4.94%) Closing price 07/8/2026 04:00 PM EasternExtended Trading$0.77 -0.02 (-2.53%) As of 06:05 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat lung cancer and other diseases of the lung at the cellular level. The company was incorporated in 2014 and is based in San Antonio, Texas.Baiya International Group NASDAQ:BIYA$0.51 +0.10 (+24.21%) Closing price 07/8/2026 04:00 PM EasternExtended Trading$0.50 -0.02 (-2.92%) As of 06:17 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.We, Baiya International Group Inc. (“Baiya”), are an offshore holding company incorporated in the Cayman Islands. We are not a Chinese operating company, but an offshore holding company incorporated in the Cayman Islands. As a holding company, we have no material operations and conduct all of our operations in China through the VIE, Shenzhen Gongwuyuan Network Technology Co., Ltd. (“Gongwuyuan”), and its subsidiaries, collectively, “PRC operating entities”. We entered into a series of Contractual Arrangements with the VIE and certain shareholders of Gongwuyuan, and this structure involves unique risks to investors. Gongwuyuan started to provide job matching services in 2017. In November 2019, Gongwuyuan began developing its cloud-based internet platform to provide one-stop crowdsourcing recruitment and SaaS-enabled HR solutions on the Gongwuyuan Platform to supplement its offline job matching services and started to position itself as a SasS-enabled HR technology company by introducing its Gongwuyuan Platform in the flexible employment marketplace. We have been and will continue to strategically develop and improve the Gongwuyuan Platform with product features that work together with our traditional offline service model to improve the job matching and HR related services in the flexible employment marketplace. Currently our business focuses on four (4) primary services: (i) job matching services; (ii) entrusted recruitment services; (iii) project outsourcing services; and (iv) labor dispatching services in the flexible employment market within China, primarily in the core manufacturing regions including the Pearl River Delta and Yangtze River Delta region. With respect to labor dispatching services, however, we are strategically reducing this service, considering the negative gross profit historically. Gongwuyuan plans to pursue its business growth by continuing to supplement its existing offline service model by introducing and integrating its Gongwuyuan Platform to provide better services in the flexible employment market throughout China. In addition, we plan to improve our services by continuing to develop and integrate digital technologies including crowdsourcing, big data and artificial intelligence to enhance the Gongwuyuan Platform. We believe these efforts will allow us to provide sufficient job matching and one-stop SaaS-enabled HR solutions to Customers, Employing Companies and workers in the flexible employment marketplace throughout China. Our principal executive offices are located in Tangxia, Dongguan, Guangdong, China.Decent NASDAQ:DXST$2.28 +0.03 (+1.33%) Closing price 07/8/2026 04:00 PM EasternExtended Trading$2.30 +0.02 (+0.66%) As of 06:16 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Decent Holding, Inc. engages in the provision of wastewater treatment by cleansing the industrial wastewater, ecological river restoration, and river ecosystem management. Its products and services include river water quality management and microbial products for water quality enhancement and pollutant cleansing purposes. The company was founded by Ding Xin Sun on January 6, 2022 and is headquartered in Yantai, China.iSpecimen NASDAQ:ISPC$2.29 -0.11 (-4.58%) Closing price 07/8/2026 04:00 PM EasternExtended Trading$2.40 +0.11 (+4.85%) As of 06:17 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, clinics, private practice groups, laboratories, blood centers, biobanks, clinical research sites, and cadaveric donation centers. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. iSpecimen Inc. was incorporated in 2009 and is headquartered in Lexington, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Why Exxon Could Be the Market's Next Big Comeback Stock Why Penguin Solutions May Be the Smartest AI Infrastructure Stock The Market Just Got Shaken—These 3 ETFs May Come Out Stronger Meta Platforms’ Cloud Push: Growth Opportunity Versus AI Concerns A Market Panic Just Discounted the AI Highway's Tollbooth Vertex’s Crinetics Deal Balances Growth with Integration Risk Apple and Broadcom Forge a Decade-Long Silicon Fortress These 3 Cash-Flow Stocks Give Investors More Than Just Growth Potential Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
